Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 13,03€(−20,89%). Der Median liegt bei 13,03€(−20,89%).
Kaufen | 7 |
Halten | 2 |
Verkaufen | 1 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.» Mehr auf globenewswire.com
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
SAN JOSE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective immediately. In addition to leading Finance, Ms. Gaeta will have responsibility for Outset's Information Technology and Human Resources organizations. She succeeds Nabeel Ahmed who is leaving the company to pursue other opportunities.» Mehr auf globenewswire.com
Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O'Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O'Boyle's appointment, the company also announced that Dale E. Jones has stepped down from the Board.» Mehr auf globenewswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 27,50 Mio | 5,37% |
Bruttoeinkommen | 10,23 Mio | 34,38% |
Nettoeinkommen | −23,83 Mio | 35,61% |
EBITDA | −19,24 Mio | 35,82% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 292,18 Mio€ |
Anzahl Aktien | 17,72 Mio |
52 Wochen-Hoch/Tief | 63,06€ - 5,08€ |
Dividenden | Nein |
Beta | 2,14 |
KGV (PE Ratio) | −8,66 |
KGWV (PEG Ratio) | 0,07 |
KBV (PB Ratio) | 5,80 |
KUV (PS Ratio) | 2,92 |
Unternehmensprofil
Name | OUTSET MED INC. NEW |
CEO | Leslie L. Trigg |
Mitarbeiter | 354 |
Assets entdecken
Shareholder von OUTSET MED INC. NEW investieren auch in folgende Assets